Life Sciences – Porsche Consulting The Magazine

Strategic TransformationWeight-Loss Drugs: Booster Shots for the Market

An effortless way to shed pounds — this ideal has become a reality for many people worldwide thanks to weight-loss shots. There have even been shortages of the GLP-1 analogs (also known as incretin mimetics). Other sectors besides healthcare are closely following the success of these drugs.

10/2024

byClaudia Doyle

High Performance EnterpriseThe MedTech Factory of the Future

Siemens Healthineers is setting new standards in medical technology at a cutting-edge plant where a digital twin provides very high transparency for the greatest efficiency.

09/2024

byDr. Christian Heinrich

InnovationBiopharmaceuticals: New Hope for Patients

A new age has dawned in the pharmaceutical sector. A large number of biological medical products are being developed to market readiness. They have the potential to treat nearly every illness, and offer hope to patients who have conditions previously considered non-treatable or ones that are very rare. For these innovations to benefit everyone, their development processes need to be improved and their remuneration models reassessed. That is the conclusion of our author, Dr. Roman Hipp, a Senior Partner at Porsche Consulting.

07/2024

byDr. Roman Hipp

SustainabilitySustainability —
A Core Business

The Boehringer Ingelheim research pharmaceutical company shows how a global corporation can be strongly committed to anchoring sustainability in a vibrant corporate culture — in all of its departments and for all of its 53,000 employees.

06/2023

byJürgen Hoffmann

InnovationThe Virtual Patient

The metaverse — a digital space that links the virtual and physical worlds — is coming. It enables people to gather and interact virtually with the sense that they are all in the same place. Many healthcare providers have already discovered its potential, and are generating considerable sales in it. Porsche Consulting The Magazine spoke with three experts about the opportunities and risks in the new healthcare metaverse.

03/2023

byMarkus Ridder

InnovationMore Precision
for Patients

Healthcare is about to enter a new paradigm. Under the heading “personalized medicine,” experts in diseases, genetics, pharmaceuticals, and IT are focusing on individualized treatments and medications in targeted ways. Insiders expect the new technologies to trigger enormous changes that will affect all stakeholders in the sector. Porsche Consulting The Magazine asked leading experts for their thoughts on these developments.

10/2022

byMarkus Ridder

Strategic TransformationInnovation:
Priority on Quality

Pharmaceutical companies play an important role in world health, and bear an enormous amount of responsibility. Quality is of the highest priority — all the more so for groundbreaking innovations — as shown by the example of Boehringer Ingelheim.

02/2022

byJürgen Hoffmann